10% of diabetics hospitalised for Covid die within 7 days

London: One in 10 Covid-19 patients who have diabetes dies within seven days of hospitalisation, a new study has claimed.

The findings, published in the journal 'Diabetologia', show that two-third (65 per cent) of Covid-19 patients with diabetes admitted to hospitals are men, and the average age of the patients is 70 years.

According to the researchers from France, the presence of diabetic complications and increasing age raises the risk of death, while increased Body Mass Index (BMI) is associated with both heightened risk of needing mechanical ventilation and with higher risk of death.

However, worse blood sugar control doesn't seem to impact a patient's outcome.

For the results, the research team analysed 1,317 patients admitted to 53 French hospitals between March 10 and March 31 this year. The majority of the hospitalised subjects had Type 2 diabetes (89 per cent) while only 3 per cent had Type 1 diabetes, with other types of diabetes in the remaining cases.

Microvascular complications (eye, kidney and nerves) were found in 47 per cent of the participants in the study, while macrovascular complications (arteries of the heart, brain, legs) were present in 41 per cent of the patients analysed.

Across all the patients in this study, by Day 7 one in five (20.3 per cent) had been intubated and were placed on a ventilator in intensive care, and one in 10 (10.3 per cent) had died.

The findings showed that the presence of microvascular or macrovascular complications each more than doubled the risk of death on the seventh day. Advanced age also substantially increased the risk of death, with the group of patients aged 75 years and more 14 times more likely to die than younger patients aged under 55 years, while patients 65-74 years old were three times more likely to die than those under 55 years.

The presence of respiratory condition obstructive sleep apnoea almost tripled the risk of death after seven days, as did the presence of dyspnoea symptoms (shortness of breath).

The study also confirmed that insulin, and indeed all treatments for modifying blood sugar, are not a risk factor for severe forms of Covid-19 and should be continued in patients with diabetes.